Clinical Trial Update: Efficacy Study of Metformin Glycinate on Postprandial Lipemia [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for metformin glycinate evaluating efficacy on postprandial lipemia in Type 2 diabetes across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• metformin glycinate (metformin glycinate)

Snippet

Sponsor: Laboratorios Silanes S.A. de C.V. | Conditions: Type 2 Diabetes | Phase 2, Phase 3 | Status: UNKNOWN